| 60.43 BATS BZX Real-Time Price As of 3:41pm ET |  +0.55 / +0.92%Today’s Change | 28.09 Today|||52-Week Range 64.64 | +9.77% Year-to-Date |
| DexCom Reports Earnings in Q4, Top Line Surges Y/Y - Analyst Blog Feb 26 / Zacks.com | 4 reasons small stocks could be studs this year Feb 25 / CNNMoney.com |
| Frontrunning: February 26 Feb 26 / Investing Channel | Will DexCom (DXCM) Loss Better Estimates this Earnings? - Analyst Blog Feb 23 / Zacks.com |
| Previous close | 59.88 |
| Today’s open | 59.82 |
| Day’s range | 59.77 - 60.85 |
| Volume | 425,999 |
| Average volume (3 months) | 627,841 |
| Market cap | $4.6B |
| Dividend yield | -- |
| Earnings growth (last year) | +28.57% |
| Earnings growth (this year) | +106.47% |
| Earnings growth (next 5 years) | +32.50% |
| Revenue growth (last year) | +62.00% |
| P/E ratio | NM |
| Price/Sales | 15.97 |
| Price/Book | 33.02 |
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | +0.18 | +0.33% |
| MRMindray Medical Inte... | +2.65 | +9.46% |
| ABMDAbiomed Inc | +0.14 | +0.23% |
| GMEDGlobus Medical Inc | -0.37 | -1.54% |
| Next reporting date | April 29, 2015 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $259.2M |
| Annual profit (last year) | -$22.4M |
| Net profit margin | -8.64% |
Sector Health Technology |
Industry Medical Specialties |
President, CEO, Chief Operating Officer & Director Kevin Ronald Sayer |
Chief Financial Officer & Vice President Jess Roper |
Corporate headquarters San Diego, California |
